Pharmacom Biovet Inc
OTC:PHMB
Income Statement
Earnings Waterfall
Pharmacom Biovet Inc
Income Statement
Pharmacom Biovet Inc
| Dec-1998 | Mar-1999 | Jun-1999 | Sep-1999 | Dec-1999 | Mar-2000 | Jun-2000 | Sep-2000 | Dec-2000 | Mar-2001 | Jun-2001 | Sep-2001 | Dec-2001 | Mar-2002 | Jun-2002 | Sep-2002 | Dec-2002 | Mar-2003 | Jun-2003 | Sep-2003 | Dec-2003 | Mar-2004 | Jun-2004 | Sep-2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(18)
|
(18)
|
(18)
|
(12)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(18)
|
(18)
|
(18)
|
(12)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(7)
N/A
|
(18)
-166%
|
(18)
0%
|
(18)
-1%
|
(12)
+37%
|
(0)
+97%
|
(1)
-70%
|
(1)
-15%
|
(0)
+28%
|
(1)
-26%
|
(0)
+26%
|
(0)
+10%
|
(0)
+5%
|
(0)
+54%
|
(0)
-149%
|
(1)
-76%
|
(1)
-24%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(7)
N/A
|
(18)
-166%
|
(18)
0%
|
(18)
-1%
|
(12)
+37%
|
(0)
+97%
|
(1)
-70%
|
(1)
-15%
|
(0)
+28%
|
(1)
-26%
|
(0)
+26%
|
(0)
+10%
|
(0)
+5%
|
(0)
+54%
|
(0)
-149%
|
(1)
-76%
|
(1)
-42%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(18)
|
(18)
|
(18)
|
(12)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Net Income (Common) |
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(7)
N/A
|
(18)
-166%
|
(18)
0%
|
(18)
-1%
|
(12)
+37%
|
(0)
+97%
|
(1)
-70%
|
(1)
-15%
|
(0)
+28%
|
(1)
-26%
|
(0)
+26%
|
(0)
+10%
|
(0)
+5%
|
(0)
+54%
|
(0)
-149%
|
(1)
-76%
|
(1)
-42%
|
|
| EPS (Diluted) |
-0.03
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3.25
N/A
|
-171
N/A
|
-324.39
-90%
|
-181.9
+44%
|
-183.2
-1%
|
-96.16
+48%
|
-2.58
+97%
|
-2.65
-3%
|
-2.65
N/A
|
-1.69
+36%
|
-2.06
-22%
|
-0.87
+58%
|
-0.62
+29%
|
-0.58
+6%
|
-0.28
+52%
|
-0.48
-71%
|
-0.69
-44%
|
-0.68
+1%
|
|